BPC-157 Dosage Guide
Complete guide to BPC-157 dosing protocols, administration methods, and safety considerations for research purposes.
Dosage Overview
Dose per Injection
250 mcg – 500 mcg
Frequency
2 times per day
Total Daily Dose
500 mcg – 1 mg
Route
subcutaneous
Cycle Length
4–6 weeks
Reconstitution
Vial Size
5 mg
BAC Water
2.0 ml
Concentration
2,500 mcg/ml
Detailed Dosage Information
Typical research dosages range from 250-500mcg administered 1-2 times daily.
Both subcutaneous and oral administration have been studied.
Administration Method
Can be administered subcutaneously near the injury site or systemically. Stable in gastric juice, making oral administration viable.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Concentration: 2.5 mg/ml
Volume to inject: 0.150 ml
Syringe units: 15.0 units — fits 0.3 ml syringe
U-100 insulin syringe (100 units = 1 ml). Verify dose with a clinician before injecting.
Pre-filled with BPC-157 defaults. Adjust values as needed.
Side Effects to Monitor
Generally well-tolerated in research. Some reports of mild nausea or dizziness at higher doses.
Safety Considerations & Risks
Limited human clinical trial data. Long-term effects not well established. Not FDA approved for human use.